Nuritas launches PeptiYouth™ an AI-discovered peptide, clinically proven, anti-aging molecule.
Nuritas, a leader in Artificial Intelligence-based peptide discovery, has launched PeptiYouth™, a peptide discovered within peas and which, following clinical trials, has been shown...
Insilico and Oxford University used machine learning to predict major clinical forms of drug cardiotoxicity.
Insilico Medicine announced this week that they, in partnership with...
Braincures raising funds to take-on AI drug discovery for Alzheimer’s and other neurological diseases with data analysis and systems biology.
The treatment of neurological diseases...
Longeveron announces Phase 2 clinical trial to evaluate the safety and efficacy of Mesenchymal Stem Cells (LMSCs) for the treatment of aging frailty in...
Extra-corporeal medical device could improve neuro outlook for end-stage renal disease patients.
Alkahest has announced its first foray into dialysis-associated dementia with a new randomised,...
Indian start-up Nugenics Research to commercialise “Elixir” after showing 54% age reversal in animal study.
The topic of using blood plasma to address human Longevity...
Peter Fedichev's Gero raising $10 million for anti-aging drug discovery and clinical trials.
The use of AI in Longevity drug discovery is nothing new, Insilico...
A Baltimore based biotech start-up, LifeSprout, has closed a $28.5million round of series A financing as it prepares for the launch of clinical trials...
OpenCures' Kevin Perrott talks about empowering the consumer with their own health data.
One of the Longevity sector’s leading voices came to the field relatively...
Yesterday at Longevity2020 was all about rejuvenation therapies, bringing together some of the world’s leading luminaries in the fight against aging.
Things kicked off with...
CEO in the front-line: Liz Parrish talks gene therapy, patient data and funding.
From academics and entrepreneurs to engineers and technologists, the battle against aging...
Co-founder Gary Hudson talks cell senescence, trials, spin-outs and the dilemma of treating age as a disease.
Every entrepreneur in Longevity has a different story...
We talk pipeline, trials, raising capital and public company challenges with Juvenescence's Dr Greg Bailey.
Longevity.Technology: Longevity is growing as a distinct investment category and Thursday’s...
Prof Steve Horvath, the founder of epigenetic age measurement, talks methylation clocks and the need for standardisation.
A key speaker on the subject will be...
Prof Ilaria Bellantuono seeks to build faster, better clinical trials for age-related disease with a focus on frailty.
Multimorbidity – an individual suffering two or...
Dr Nir Barzilai predicts that rapamycin could decrease severity of coronavirus in the elderly by 50%.
Longevity.Technology: When it comes to the world of Longevity...
Telomerase therapy ready for human Alzheimer’s trials.
“There have been more than 400 registered trials for Alzheimer's and, by global consensus, every single one has...
Start-up NemaLife evolves from platform technology to services provider to identify chemicals that have both positive and negative effects on Longevity.
The use of the...
We take a trip down Lifespan.io's Rejuvenation Roadmap – and it's a journey towards Longevity progress.
Lifespan.io is a US-based non-profit organisation that seeks to...
Non-invasive therapy that comes in a bottle could be the Longevity crème de la crème.
Therapeutic substances like arnica, turmeric and witch hazel have been...
